LillyDirect (Zepbound) vs. Noom Med: prices, fine print, and the honest verdict

Tirzepatide pricing

LillyDirect (Zepbound): $449 a month all-in at the 10 mg maintenance basis, dose-scaled from a $299 entry, no membership fee. Noom Med does not offer tirzepatide.

Semaglutide pricing

Only Noom Med publishes a semaglutide price here: Semaglutide runs $199 a month all-in — capped at 0.6 mg, a quarter of the trial dose. LillyDirect (Zepbound) doesn't sell compounded semaglutide — its lane is brand fulfillment.

Different products, not just different prices

LillyDirect (Zepbound) fulfills the FDA-approved product — reviewed manufacturing, verified identity and sterility, stable legal status — while Noom Med sells compounded medication: pharmacy-prepared, not FDA-reviewed, and operating under the narrower post-shortage pathways our legal guide tracks. The compounded discount is partly a risk premium; whether it's worth taking depends on the pharmacy behind it and your tolerance for regulatory turbulence.

Transparency

LillyDirect (Zepbound): Source-verified (verified 2026-08-09); names its pharmacy — Eli Lilly direct / retail partners. Noom Med: Source-verified (verified 2026-08-08); names its pharmacy — Tailor Made Compounding (named). In this market, a named pharmacy and a dated, source-verified price are worth real money — they are what let you check the claim instead of trusting it.

Commitment & cancellation

LillyDirect (Zepbound): 45-day refill cadence to keep pricing; no subscription; refill-window rules apply. Noom Med: 12-week cycles; 12-week billing cycles.

Two ladders, side by side

Put both dose ladders on the same axis and the structures argue for themselves: LillyDirect (Zepbound) steps $299 → $399 → $449 and holds $449 from 7.5 mg up (four-month titration: $1,596). A flat ladder makes dose decisions purely clinical; a scaled one attaches an invoice to every escalation — including the post-plateau bump from 10 to 12.5 mg that many patients eventually face. Full framework: the titration cost guide.

The semaglutide board

Only Noom Med fields a verified semaglutide price here — $199/month all-in (#None of 19) — while LillyDirect (Zepbound) focuses its published pricing on tirzepatide. For a buyer starting on the cheaper molecule with a likely upgrade later, single-molecule programs mean a future re-shop; dual-molecule ones price the whole arc.

The five normalizations, applied to this pair

1 · All-in, not advertised. LillyDirect (Zepbound)'s ranked figure is $449, with no membership to add; Noom Med publishes no figure to normalize. 2 · Maintenance basis. LillyDirect (Zepbound) scales from $299 to $449, and the 10 mg figure is the one ranked. 3 · Terms separated. LillyDirect (Zepbound): standing $449, no prepaid tier — standing rates rank, prepaid effectives are labeled beside them. 4 · Evidence tiered. LillyDirect (Zepbound): source-verified, read 2026-08-09; Noom Med: source-verified, read 2026-08-08. 5 · Pharmacy weighed. LillyDirect (Zepbound) names Eli Lilly direct / retail partners; Noom Med names Tailor Made Compounding (named) — in a pharmacy-variance market, disclosure is a scored asset. Run the same five on any roundup you read and most published “cheapest” lists reorder themselves.

Fine print, itemized

LillyDirect (Zepbound): no membership — the medication figure is the billed figure; no subscription; refill-window rules apply; commitment: 45-day refill cadence to keep pricing. Noom Med: no membership — the medication figure is the billed figure; 12-week billing cycles; commitment: 12-week cycles. The pattern to police on both sides is the same: memberships that outlive the medication order, renewal-relative cancellation deadlines, and prepaid terms whose refund language matters more than their discount in a year of live litigation. Cancel in writing; screenshot everything.

Transparency, audited

LillyDirect (Zepbound) carries source-verified pricing (last read 2026-08-09); pharmacy disclosure is its strong suit — Eli Lilly direct / retail partners, manufacturer direct. Noom Med carries source-verified pricing (last read 2026-08-08); pharmacy disclosure is its strong suit — Tailor Made Compounding (named), named 503A/503B partner. Our weighting is unapologetic: in a market of identical molecule names, a dated source-verified price and a named pharmacy are the two claims a buyer can actually check, and they carry 25 of 100 formula points between them — the methodology shows the math, and the pharmacy guide decodes every answer the five questions can return.

Switching between them

Moving from LillyDirect (Zepbound) to Noom Med (or back) is administratively unglamorous: complete the new program's intake, let its prescriber issue a fresh prescription to its pharmacy, and cancel the old subscription in writing — prescriptions don't transfer between telehealth programs, and neither do prepaid balances, which is the quiet reason month-to-month terms are worth their premium.

Refills, shipping, and the week-to-week reality

The unglamorous layer — how the medication actually reaches you and stays on schedule — splits like this: LillyDirect (Zepbound): shipping included (or same-day retail pickup); consultation bring your own prescription (telehealth partners available); prescription required visit model; a ~45-day refill cadence guards the self-pay tiers (lapse and fills reprice $599–$1,049 until re-enrollment). Noom Med: shipping included; consultation included; async visit model. Cold-chain shipments run 3–7 days across the market; the recurring failure modes are refill-timing gaps and pharmacy backlogs, so whichever program wins here, order refills a week early and confirm the pharmacy’s current turnaround at intake.

Who should pick which

Pick LillyDirect (Zepbound) if only the FDA-approved product will do. Pick Noom Med if its published terms happen to fit your state, format, or timing. Neither answer is universal — which is the argument for choosing from data with dates on it rather than from whichever ad loaded first.

If neither one fits

The dataset's bench is deep; the closest verified third options to this matchup's price band are Eden at $408 (dose-scaled, $99 membership included); MEDVi at $399 (flat, no membership); Remedy Meds at $399 (flat, no membership) — or skip straight to the rankings page, where every standard “cheapest / best / no-commitment” question is answered in one sourced sentence.

The verdict

This one is a product decision more than a price decision — cheapest-possible compounded versus FDA-approved brand. Both records, with dates and sources, live in the pricing database.